DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Alankit vs Nifty 50: Share Price Performance Compared

Univest 2 hrs ago·7 Sept 2026, 8:11 am

Alankit Limited has recently underperformed the benchmark Nifty 50 index, trading below its key moving averages. This divergence suggests that the broader market sentiment is currently favoring large-cap leaders over this specific mid-cap financial services company.

For investors, this performance gap highlights the importance of evaluating a stock's relative strength against its sector and the overall market. It indicates that current market conditions may not be supportive of Alankit's specific business narrative at this time.

Moving forward, investors should monitor whether Alankit can reclaim its technical levels and stabilize its share price. Keeping an eye on broader market trends and the company's quarterly results will be crucial to understanding if the stock can regain its footing.